SCHEMBL32688254

SCHEMBL32688254

N#Cc1c(-c2cccc(C(=O)Nc3ccc(C(F)(F)F)cc3)c2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UGCG Q16739 1/20 0.40
▸ GGPS1 O95749 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SIRT2 Q8IXJ6 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ ABL1 P00519 3/20 0.36
▸ DDR2 Q16832 1/20 0.36
▸ EPHX2 P34913 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ DDR1 Q08345 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688221 0.91 SIRT2 (0.46) MEN1KMT2ASIRT2HTTPOLB
SCHEMBL32688271 0.91 ALDH1A1 (0.42) MEN1KMT2ANPC1RAB9ASIRT2
SCHEMBL32688016 0.88 KISS1R (0.42) KMT2ASIRT2POLBMAPT
SCHEMBL32688014 0.87 ULK1 (0.38) MEN1KMT2AHTTPOLBMAPT
SCHEMBL32688358 0.85 PSMD14 (0.43) SIRT2POLBBRAF
SCHEMBL32688056 0.84 MET (0.41) MEN1KMT2AHTTPOLBMAPT
SCHEMBL32688247 0.83 ACMSD (0.44) KMT2A
SCHEMBL32688196 0.82 MAPK14 (0.38) KMT2A
SCHEMBL32688149 0.81 TNKS2 (0.40) MEN1KMT2APOLBMAPT
SCHEMBL32688183 0.80 KISS1R (0.45) KMT2AABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK UGCG 3951/4885GGPS1 2340/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback